{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:40Z","timestamp":1793089120632,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dept of Women's and Children's Health, Uppsala university"},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["R-968023"],"award-info":[{"award-number":["R-968023"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010342","name":"Gillbergska stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Our aim was attempting to find proteins involved in the pain process and correlating with pain but not degree of inflammation in children with juvenile idiopathic arthritis (JIA), using a proteomics panel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 87 plasma samples were collected from 51 children with JIA (51 at diagnosis in a higher disease activity state, 18 at follow-up in a lower disease activity state) and 18 healthy controls. Relative levels of 92 proteins related to a wide range of biological processes in inflammation were obtained using a proximity extension assay panel. Comparisons between children with and without JIA, in different disease categories, by juvenile disease activity score (JADAS27) and degree of pain on a visual analogue scale (VAS), were performed using parametric and non-parametric statistical methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen proteins involved in arthritic inflammation, such as interleukin 6 (IL-6) and S100 protein A12, were higher in patients with JIA than controls, seven decreased significantly during treatment, and 18 correlated significantly with JADAS27. Three proteins correlated with pain VAS scores in unadjusted analyses: the glial cell line-derived neurotrophic factor (GDNF), transforming growth factor beta, and IL-18R1. Levels of GDNF correlated significantly with pain VAS scores but not with JADAS27.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Plasma levels of 18 of 92 tested proteins correlated with degree of disease activity. Levels of three proteins correlated with pain, and levels of one, GDNF, originating from neural cells, correlated with pain without correlating with inflammatory degree, suggesting that it may play a role in pain in JIA. Further studies in larger cohorts are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-023-04181-0","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T10:02:29Z","timestamp":1689415349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An explorative study on proteomic analyses related to inflammation and pain in children with juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"23","author":[{"given":"Andreas","family":"Elfving","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Harila-Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-0453","authenticated-orcid":false,"given":"Lillemor","family":"Berntson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"2","key":"4181_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"4","key":"4181_CR2","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/art.20125","volume":"50","author":"D Foell","year":"2004","unstructured":"Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004;50(4):1286\u201395.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4181_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","volume":"43","author":"M Frosch","year":"2000","unstructured":"Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000;43(3):628\u201337.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4181_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.40727","volume":"71","author":"CH Hinze","year":"2019","unstructured":"Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, et al. Serum S100A8\/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019;71(3):451\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"4181_CR5","first-page":"123","volume":"35 Suppl 107","author":"G Giancane","year":"2017","unstructured":"Giancane G, Alongi A, Rosina S, Calandra S, Consolaro A, Ravelli A. Open issues in the assessment and management of pain in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2017;35 Suppl 107(5):123\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4181_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.38223","volume":"66","author":"MH Bromberg","year":"2014","unstructured":"Bromberg MH, Connelly M, Anthony KK, Gil KM, Schanberg LE. Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study. Arthritis Rheumatol. 2014;66(2):462\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4181_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-11-21","volume":"11","author":"JJ Lomholt","year":"2013","unstructured":"Lomholt JJ, Thastum M, Herlin T. Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment. Pediatr Rheumatol Online J. 2013;11(1):21.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"4181_CR8","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.1021\/acsomega.1c06681","volume":"7","author":"H Sato","year":"2022","unstructured":"Sato H, Inoue Y, Kawashima Y, Nakajima D, Ishikawa M, Konno R, et al. In-Depth Serum Proteomics by DIA-MS with In Silico Spectral Libraries Reveals Dynamics during the Active Phase of Systemic Juvenile Idiopathic Arthritis. ACS Omega. 2022;7(8):7012\u201323.","journal-title":"ACS Omega"},{"issue":"1","key":"4181_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12969-021-00660-9","volume":"19","author":"H Qu","year":"2021","unstructured":"Qu H, Sundberg E, Aulin C, Neog M, Palmblad K, Horne AC, et al. Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study. Pediatr Rheumatol Online J. 2021;19(1):173.","journal-title":"Pediatr Rheumatol Online J"},{"key":"4181_CR10","doi-asserted-by":"crossref","unstructured":"Brescia AC, Simonds MM, Sullivan KE, Rose CD. Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis. Proteomics Clin Appl. 2017;11(5\u20136):1600088.","DOI":"10.1002\/prca.201600088"},{"issue":"1","key":"4181_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12969-022-00662-1","volume":"20","author":"H Van Der Heijden","year":"2022","unstructured":"Van Der Heijden H, Fatou B, Sibai D, Hoyt K, Taylor M, Cheung K, et al. Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2022;20(1):3.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"4181_CR12","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192.","journal-title":"PLoS ONE"},{"issue":"1","key":"4181_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12969-016-0085-5","volume":"14","author":"A Consolaro","year":"2016","unstructured":"Consolaro A, Giancane G, Schiappapietra B, Davi S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):23.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"4181_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J R Stat Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B"},{"issue":"2","key":"4181_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14397595.2019.1574697","volume":"29","author":"S Akioka","year":"2019","unstructured":"Akioka S. Interleukin-6 in juvenile idiopathic arthritis. Mod Rheumatol. 2019;29(2):275\u201386.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"4181_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2741\/s53","volume":"2","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz Z, Vegvari A, Szabo Z, Koch AE. Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed). 2010;2(1):153\u201367.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"7","key":"4181_CR17","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/art.24602","volume":"60","author":"C Hintzen","year":"2009","unstructured":"Hintzen C, Quaiser S, Pap T, Heinrich PC, Hermanns HM. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. Arthritis Rheum. 2009;60(7):1932\u201343.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4181_CR18","first-page":"1772","volume":"28","author":"M Nagashima","year":"2001","unstructured":"Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, et al. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol. 2001;28(8):1772\u20138.","journal-title":"J Rheumatol"},{"issue":"12","key":"4181_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nri3766","volume":"14","author":"S Rutz","year":"2014","unstructured":"Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines\u2013from host defence to tissue homeostasis. Nat Rev Immunol. 2014;14(12):783\u201395.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4181_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1189\/jlb.0910528","volume":"89","author":"JW Shui","year":"2011","unstructured":"Shui JW, Steinberg MW, Kronenberg M. Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol. 2011;89(4):517\u201323.","journal-title":"J Leukoc Biol"},{"key":"4181_CR21","doi-asserted-by":"crossref","unstructured":"Berkhout LC, L\u2019Ami MJ, Ruwaard J, Hart MH, Heer PO-D, Bloem K, et al. Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Sci Transl Med. 2019;11(477):eaat3356.","DOI":"10.1126\/scitranslmed.aat3356"},{"issue":"20","key":"4181_CR22","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.3390\/ijms20204996","volume":"20","author":"V Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez V, Aguilar R. Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications. Int J Mol Sci. 2019;20(20):4996.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4181_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/acr.23853","volume":"72","author":"M Glerup","year":"2020","unstructured":"Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, et al. Long-term outcomes in juvenile idiopathic arthritis: 18 years of follow-up in the population-based Nordic Juvenile Idiopathic Arthritis (JIA) cohort. Arthritis Care Res (Hoboken). 2020;72(4):507\u201316.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"5","key":"4181_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.semarthrit.2015.10.008","volume":"45","author":"W Armbrust","year":"2016","unstructured":"Armbrust W, Siers NE, Lelieveld OTHM, Mouton LJ, Tuinstra J, Sauer P. Fatigue in patients with juvenile idiopathic arthritis: A systematic review of the literature. Semin Arthritis Rheum. 2016;45(5):587\u201395.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"4181_CR25","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/rheumatology\/ker256","volume":"50","author":"Y Butbul Aviel","year":"2011","unstructured":"Butbul Aviel Y, Stremler R, Benseler SM, Cameron B, Laxer RM, Ota S, et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology. 2011;50(11):2051\u201360.","journal-title":"Rheumatology"},{"issue":"2","key":"4181_CR26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/rheumatology\/kel218","volume":"46","author":"R Gutierrez-Suarez","year":"2006","unstructured":"Gutierrez-Suarez R, Pistorio A, Cespedes Cruz A, Norambuena X, Flato B, Rumba I, et al. Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology. 2006;46(2):314\u201320.","journal-title":"Rheumatology"},{"issue":"5","key":"4181_CR27","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.10986","volume":"48","author":"LE Schanberg","year":"2003","unstructured":"Schanberg LE, Anthony KK, Gil KM, Maurin EC. Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum. 2003;48(5):1390\u20137.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4181_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40272-014-0094-0","volume":"16","author":"JE Weiss","year":"2014","unstructured":"Weiss JE, Luca NJ, Boneparth A, Stinson J. Assessment and management of pain in juvenile idiopathic arthritis. Paediatr Drugs. 2014;16(6):473\u201381.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"4181_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/art.10661","volume":"47","author":"S Dhanani","year":"2002","unstructured":"Dhanani S, Quenneville J, Perron M, Abdolell M, Feldman BM. Minimal difference in pain associated with change in quality of life in children with rheumatic disease. Arthritis Rheum. 2002;47(5):501\u20135.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"4181_CR30","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3899\/jrheum.120793","volume":"40","author":"A Leegaard","year":"2013","unstructured":"Leegaard A, Lomholt JJ, Thastum M, Herlin T. Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-sectional Study. J Rheumatol. 2013;40(7):1212\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"4181_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1546-0096-12-39","volume":"12","author":"L Cornelissen","year":"2014","unstructured":"Cornelissen L, Donado C, Kim J, Chiel L, Zurakowski D, Logan DE, et al. Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study. Pediatr Rheumatol. 2014;12(1):39.","journal-title":"Pediatr Rheumatol"},{"issue":"7","key":"4181_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/acr.23715","volume":"71","author":"ED Arnstad","year":"2019","unstructured":"Arnstad ED, Rypdal V, Peltoniemi S, Herlin T, Berntson L, Fasth A, et al. Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study. Arthritis Care Res (Hoboken). 2019;71(7):961\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"4181_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/rheumatology\/kex308","volume":"57","author":"R Raoof","year":"2018","unstructured":"Raoof R, Willemen H, Eijkelkamp N. Divergent roles of immune cells and their mediators in pain. Rheumatology (Oxford). 2018;57(3):429\u201340.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"4181_CR34","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2174\/1570159X18666201116143422","volume":"19","author":"F Ferrini","year":"2021","unstructured":"Ferrini F, Salio C, Boggio EM, Merighi A. Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance. Curr Neuropharmacol. 2021;19(8):1225\u201345.","journal-title":"Curr Neuropharmacol"},{"key":"4181_CR35","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3389\/fimmu.2019.03061","volume":"10","author":"G Goncalves Dos Santos","year":"2019","unstructured":"Goncalves Dos Santos G, Delay L, Yaksh TL, Corr M. Neuraxial Cytokines in Pain States. Front Immunol. 2019;10:3061.","journal-title":"Front Immunol"},{"issue":"2","key":"4181_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/ejn.14985","volume":"53","author":"SF Magalh\u00e3es","year":"2021","unstructured":"Magalh\u00e3es SF, Manzo LP, Faria FM, Oliveira-Fusaro MC, Nishijima CM, Vieira WF, et al. Inflammatory pain in peripheral tissue depends on the activation of the TNF-\u03b1 type 1 receptor in the primary afferent neuron. Eur J Neurosci. 2021;53(2):376\u201389.","journal-title":"Eur J Neurosci."},{"key":"4181_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbi.2020.08.004","volume":"90","author":"CHT Kwok","year":"2020","unstructured":"Kwok CHT, Learoyd AE, Canet-Pons J, Trang T, Fitzgerald M. Spinal interleukin-6 contributes to central sensitisation and persistent pain hypersensitivity in a model of juvenile idiopathic arthritis. Brain Behav Immun. 2020;90:145\u201354.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"4181_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00441-020-03287-6","volume":"382","author":"AF Cintron-Colon","year":"2020","unstructured":"Cintron-Colon AF, Almeida-Alves G, Boynton AM, Spitsbergen JM. GDNF synthesis, signaling, and retrograde transport in motor neurons. Cell Tissue Res. 2020;382(1):47\u201356.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"4181_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/14728222.2016.1085972","volume":"20","author":"A Merighi","year":"2016","unstructured":"Merighi A. Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain. Expert Opin Ther Targets. 2016;20(2):193\u2013208.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"4181_CR40","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/art.38336","volume":"66","author":"AC Brescia","year":"2014","unstructured":"Brescia AC, Simonds MM, McCahan SM, Fawcett PT, Rose CD. The role of transforming growth factor beta signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor beta signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthritis Rheumatol. 2014;66(5):1352\u201362.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4181_CR41","doi-asserted-by":"publisher","first-page":"e0262074","DOI":"10.1371\/journal.pone.0262074","volume":"17","author":"YC Liu","year":"2022","unstructured":"Liu YC, Hsiao HT, Wang JC, Wen TC, Chen SL. TGF-beta1 in plasma and cerebrospinal fluid can be used as a biological indicator of chronic pain in patients with osteoarthritis. PLoS ONE. 2022;17(1):e0262074.","journal-title":"PLoS ONE"},{"key":"4181_CR42","doi-asserted-by":"crossref","unstructured":"Koper-Lenkiewicz OM, Sutkowska K, Wawrusiewicz-Kurylonek N, Kowalewska E, Matowicka-Karna J. Proinflammatory cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-\u03b1) single nucleotide polymorphisms in rheumatoid arthritis\u2014a literature review. Int J Mol Sci. 2022;23(4):2106.","DOI":"10.3390\/ijms23042106"},{"issue":"4","key":"4181_CR43","first-page":"823","volume":"34","author":"AP Lotito","year":"2007","unstructured":"Lotito AP, Campa A, Silva CA, Kiss MH, Mello SB. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34(4):823\u201330.","journal-title":"J Rheumatol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04181-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04181-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T06:30:21Z","timestamp":1729751421000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04181-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4181"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04181-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional ethics committee in Uppsala County (reference 2006\/327; 2006\/327\/1; 2006\/327\/3; 2021\u201301614). Verbal informed consent was obtained from parents and children. Written informed consent was obtained from the parents and from children at the age of twelve or older. Participation was voluntary and participants could withdraw at any time without giving a reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}